Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06218875 · ClinicalTrials.gov registry record
Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis
A clinical trial of AAA - Abdominal Aortic Aneurysm, sponsored by W.L.Gore & Associates.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 20
- Study locations
NCT06218875: Recruiting study of AAA - Abdominal Aortic Aneurysm, sponsored by W.L.Gore & Associates.
NCT06218875 is a study of AAA - Abdominal Aortic Aneurysm that is actively recruiting participants, run by W.L.Gore & Associates. The registered enrollment target is 2,000 participants. The trial reports 20 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06218875, a study of AAA - Abdominal Aortic Aneurysm, is actively recruiting participants, sponsored by W.L.Gore & Associates.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
A prospective, observational post-market registry collecting outcomes through a 10-year post procedure follow-up for patients treated with the GORE® EXCLUDER® Conformable AAA Endoprosthesis (EXCC Device) or the GORE® EXCLUDER® Iliac Branch Endoprosthesis (IBE Device) as a part of routine clinical practice.
Primary Outcome
Successful access, delivery, and accurate deployment of the device to the intended location, and retrieval of the delivery system.
Conditions Studied
Study Locations (20)
California
- University of California - Irvine - Irvine
- University of Southern California - Los Angeles
- University of Southern California - Los Angeles
- Stanford University School of Medicine - Palo Alto
- Stanford University School of Medicine - Stanford
Georgia
- VA Medical Center- Atlanta - Atlanta
- Emory Saint Joseph's Hospital - Atlanta
- Augusta University Medical Center - Augusta
- Atlanta VA Medical Center - Decatur
Florida
- Mount Sinai Vascular Institute - Miami Beach
- University of South Florida - Tampa
- University of South Florida - Tampa
Illinois
- University of Chicago Hospital - Chicago
- Endeavor Health - Evanston
Arkansas
- Central Arkansas Veteran's Healthcare System - Little Rock
Indiana
- St. Vincent Medical Group, Inc. - Indianapolis
Kentucky
- University of Louisville - Louisville
Louisiana
- Our Lady of the Lake Regional Medical Center - Baton Rouge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2024-05-07 |
| Est. Completion | 2042-09-30 |
What NCT06218875 shows while recruiting
NCT06218875 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with AAA - Abdominal Aortic Aneurysm appearing as the primary indexed condition, and to 0 interventions.
NCT06218875 names 20 study sites across 10 states, led by California, Georgia, Florida.
Frequently Asked Questions
What is clinical trial NCT06218875 about?
NCT06218875 is a clinical study titled "Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis". A prospective, observational post-market registry collecting outcomes through a 10-year post procedure follow-up for patients treated with the GORE® EXCLUDER® Conformable AAA Endoprosthesis (EXCC Device) or the GORE® EXCLUDER® Iliac Branch Endoprosthesis (IBE Device) as a part of routine clinical pr...
What is the current status of trial NCT06218875?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2024-05-07. Estimated completion is 2042-09-30.
What conditions does trial NCT06218875 study?
This clinical trial studies the following conditions: AAA - Abdominal Aortic Aneurysm.
Who is sponsoring clinical trial NCT06218875?
This trial is sponsored by W.L.Gore & Associates, which has 53 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06218875 being conducted?
This trial has 20 study locations across Arkansas, California, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for AAA - Abdominal Aortic Aneurysm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI